Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02757391
Title T Cell Immunotherapy Plus Anti-PD1 Antibody in Advanced Solid Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

gastrointestinal system cancer

Therapies

Aldesleukin + Cyclophosphamide + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.